156
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Clinical Factors Associated with Serum Magnesium Concentration in Patients Undergoing Peritoneal Dialysis: A Single-Center Observational Study

ORCID Icon, &
Pages 185-195 | Published online: 24 May 2022

References

  • Gröber U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients. 2015;7(9):8199–8226. doi:10.3390/nu7095388
  • Pickering G, Mazur A, Trousselard M, et al. Magnesium status and stress: the vicious circle concept revisited. Nutrients. 2020;12:12. doi:10.3390/nu12123672
  • Volpe SL. Magnesium in disease prevention and overall health. Adv Nutr. 2013;4(3):378s–83s. doi:10.3945/an.112.003483
  • Sakaguchi Y. The emerging role of magnesium in CKD. Clin Exp Nephrol. 2022;26(5):379–384. doi:10.1007/s10157-022-02182-4
  • Hansen BA, Bruserud Ø. Hypomagnesemia in critically ill patients. J Intensive Care. 2018;6:21. doi:10.1186/s40560-018-0291-y
  • Pham PC, Pham PA, Pham SV, Pham PT, Pham PM, Pham PT. Hypomagnesemia: a clinical perspective. Int J Nephrol Renovasc Dis. 2014;7:219–230. doi:10.2147/IJNRD.S42054
  • Gröber U. Magnesium and drugs. Int J Mol Sci. 2019;20:9. doi:10.3390/ijms20092094
  • Blaszczyk U, Duda-Chodak A. Magnesium: its role in nutrition and carcinogenesis. Rocz Panstw Zakl Hig. 2013;64(3):165–171.
  • Mozos I. Laboratory markers of ventricular arrhythmia risk in renal failure. Biomed Res Int. 2014;2014:509204. doi:10.1155/2014/509204
  • Foglia PE, Bettinelli A, Tosetto C, et al. Cardiac work up in primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome). Nephrol Dial Transplant. 2004;19(6):1398–1402. doi:10.1093/ndt/gfh204
  • Wong ET, Rude RK, Singer FR, Shaw ST Jr. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol. 1983;79(3):348–352. doi:10.1093/ajcp/79.3.348
  • Floege J. Magnesium in CKD: more than a calcification inhibitor? J Nephrol. 2015;28(3):269–277. doi:10.1007/s40620-014-0140-6
  • Wyskida K, Witkowicz J, Chudek J, Więcek A. Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease. J Ren Nutr. 2012;22(1):19–26. doi:10.1053/j.jrn.2011.03.001
  • Mori H, Suzuki H, Hirai Y, et al. Clinical features of hypermagnesemia in patients with functional constipation taking daily magnesium oxide. J Clin Biochem Nutr. 2019;65(1):76–81. doi:10.3164/jcbn.18-117
  • van de Wal-Visscher ER, Kooman JP, van der Sande FM. Magnesium in chronic kidney disease: should we care? Blood Purif. 2018;45(1–3):173–178. doi:10.1159/000485212
  • Bokhari SR, Siriki R, Teran FJ, Batuman V. Fatal hypermagnesemia due to laxative use. Am J Med Sci. 2018;355(4):390–395. doi:10.1016/j.amjms.2017.08.013
  • Van Laecke S. Hypomagnesemia and hypermagnesemia. Acta Clin Belg. 2019;74(1):41–47. doi:10.1080/17843286.2018.1516173
  • Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014;85(1):174–181. doi:10.1038/ki.2013.327
  • Yu L, Song J, Lu X, Zu Y, Li H, Wang S. Association between serum magnesium and erythropoietin responsiveness in hemodialysis patients: a cross-sectional study. Kidney Blood Press Res. 2019;44(3):354–361. doi:10.1159/000500921
  • Hori M, Yasuda K, Takahashi H, Yamazaki C, Morozumi K, Maruyama S. Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients. PLoS One. 2021;16(5):e0251912. doi:10.1371/journal.pone.0251912
  • Lu C, Wang Y, Wang D, et al. Hypomagnesemia and short-term mortality in elderly maintenance hemodialysis patients. Kidney Dis. 2020;6(2):109–118. doi:10.1159/000504601
  • de Francisco AL M, Rodríguez M. Magnesium - its role in CKD. Nefrologia. 2013;33(3):389–399. doi:10.3265/Nefrologia.pre2013.Feb.11840
  • Cho MS, Lee KS, Lee YK, et al. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Korean J Intern Med. 2002;17(2):114–121. doi:10.3904/kjim.2002.17.2.114
  • Ye H, Zhang X, Guo Q, et al. Prevalence and factors associated with hypomagnesemia in Southern Chinese continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 2013;33(4):450–454. doi:10.3747/pdi.2012.00164
  • Takahashi S, Okada K, Yanai M. Magnesium and parathyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1994;14(1):75–78. doi:10.1177/089686089401400115
  • Tsai S, Zhao H, Wu B, Zuo L, Wang M. Serum magnesium abnormality and influencing factors of serum magnesium level in peritoneal dialysis patients: a single-center study in northern China. Blood Purif. 2018;45(1–3):110–117. doi:10.1159/000485315
  • Working Group Committee for Preparation of Guidelines for Peritoneal Dialysis JSfDT, Japanese Society for Dialysis Therapy. 2009 Japanese society for dialysis therapy guidelines for peritoneal dialysis. Ther Apher Dial. 2010;14(6):489–504. doi:10.1111/j.1744-9987.2010.00901.x
  • Yamamoto H, Nishi S, Tomo T, et al. 2015 Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease. Ren Replace Ther. 2017;3(1):36.
  • van Hoeck KJM, Rusthoven E, Vermeylen L, et al. Nutritional effects of increasing dialysis dose by adding an icodextrin daytime dwell to Nocturnal Intermittent Peritoneal Dialysis (NIPD) in children. Nephrol Dial Transplant. 2003;18(7):1383–1387. doi:10.1093/ndt/gfg120
  • Badve SV, Zimmerman DL, Knoll GA, Burns KD, McCormick BB. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics. Clin J Am Soc Nephrol. 2008;3(6):1711–1717. doi:10.2215/CJN.00190108
  • Diaz-Buxo JA, Walker PJ, Chandler JT, Burgess WP, Farmer CD. Experience with intermittent peritoneal dialysis and continuous cyclic peritoneal dialysis. Am J Kidney Dis. 1984;4(3):242–248. doi:10.1016/S0272-6386(84)80099-2
  • Venkataraman V, Nolph KD. Utilization of PD modalities: evolution. Semin Dial. 2002;15(6):380–384. doi:10.1046/j.1525-139X.2002.00095.x
  • Lo W-K, Bargman JM, Burkart J, et al. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int. 2006;26(5):520–522. doi:10.1177/089686080602600502
  • Teitelbaum I, Burkart J. Peritoneal dialysis. Am J Kidney Dis. 2003;42(5):1082–1096. doi:10.1016/j.ajkd.2003.08.036
  • Masakane I, Tsubakihara Y, Akiba T, Watanabe Y, Iseki K. The most recent trends of peritoneal dialysis in Japan. Perit Dial Int. 2008;28(Suppl 3):S27–S31. doi:10.1177/089686080802803s06
  • Kawanishi H, Marshall MR, Zhao J, et al. Mortality, hospitalization and transfer to haemodialysis and hybrid therapy, in Japanese peritoneal dialysis patients. Perit Dial Int. 2021;42(3):305–313. doi:10.1177/08968608211016127
  • Ohbal T, Shiraishi T, Kabaya T, Watanabe S. [Evaluation of Payne’s formula for the correction of calcium: comparison with improved calcium and albumin measurement methods]. Rinsho Byori. 2014;62(2):133–138. Japanese.
  • Tabata M, Totani M, Murachi T. A chemiluminometric method for NADPH and NADH using a two-enzyme bioreactor and its application to the determination of magnesium in serum. Biomed Chromatogr. 1990;4(3):123–127. doi:10.1002/bmc.1130040310
  • Rude RK, Oldham SB, Singer FR. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol. 1976;5(3):209–224. doi:10.1111/j.1365-2265.1976.tb01947.x
  • Ishida Y, Tabuchi A. Severe hypermagnesemia with normal renal function can improve with symptomatic treatment. Case Rep Emerg Med. 2020;2020:2918249. doi:10.1155/2020/2918249
  • Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007;18(10):2649–2652. doi:10.1681/ASN.2007070792
  • Fulchiero R, Seo-Mayer P. Bartter syndrome and Gitelman syndrome. Pediatr Clin North Am. 2019;66(1):121–134. doi:10.1016/j.pcl.2018.08.010
  • Gug C, Mihaescu A, Mozos I. Two mutations in the thiazide-sensitive NaCl co-transporter gene in a Romanian Gitelman syndrome patient: case report. Ther Clin Risk Manag. 2018;14:149–155. doi:10.2147/TCRM.S150483
  • Hudali T, Takkar C. Hypocalcemia and hyperkalemia during magnesium infusion therapy in a pre-eclamptic patient. Clin Case Rep. 2015;3(10):827–831. doi:10.1002/ccr3.356
  • Davies SJ, Zhao J, Morgenstern H, et al. Low serum potassium levels and clinical outcomes in peritoneal dialysis-international results from PDOPPS. Kidney Int Rep. 2021;6(2):313–324. doi:10.1016/j.ekir.2020.11.021
  • Katopodis KP, Koliousi EL, Andrikos EK, Pappas MV, Elisaf MS, Siamopoulos KC. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration. Artif Organs. 2003;27(9):853–857. doi:10.1046/j.1525-1594.2003.07193.x
  • Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, Zambrano-Galvan G, Guerrero-Romero F. Effect of magnesium supplementation on plasma c-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. Curr Pharm Des. 2017;23(31):4678–4686. doi:10.2174/1381612823666170525153605
  • Nielsen FH. Dietary magnesium and chronic disease. Adv Chronic Kidney Dis. 2018;25(3):230–235. doi:10.1053/j.ackd.2017.11.005
  • Hamedifard Z, Farrokhian A, Reiner Ž, et al. The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Lipids Health Dis. 2020;19(1):112. doi:10.1186/s12944-020-01298-4
  • Chase LR, Slatopolsky E, Krinski T. Secretion and metabolic efficacy of parathyroid hormone in patients with severe hypomagnesemia. J Clin Endocrinol Metab. 1974;38(3):363–371. doi:10.1210/jcem-38-3-363
  • Nagano N, Ito K, Honda M. The magnesium included as a pharmaceutical excipient in phosphate binders might affect the serum magnesium levels of dialysis patients. J Jpn Soc Dial Ther. 2016;49(9):571–580. doi:10.4009/jsdt.49.571